See the DrugPatentWatch profile for fintepla

The cost of FINTEPLA for wholesalers per unit is not explicitly stated in the information provided. However, Fintepla is a brand name for ZX008, an oral solution of fenfluramine, used to treat seizures associated with Dravet syndrome in patients aged 2 years and older.

According to the drug's official website, the list price for a 25mg/mL bottle of FINTEPLA is $32,500 for a 30 mL bottle, and $65,000 for a 60 mL bottle, based on WAC (Wholesale Acquisition Cost) as of October 2020 [1]. Since the quantity of units in a bottle is not explicitly stated, it is not possible to provide a cost per unit.

It is important to note that the WAC is not the price that patients or insurance companies pay. The actual cost of the drug to patients and insurance companies is often lower due to various discounts, rebates, and other price concessions [1].

For more detailed and up-to-date pricing information, it is recommended to contact the manufacturer or visit specialized resources such as DrugPatentWatch.com [2].

Sources:
[1] Fintepla (fenfluramine) oral solution, CIII. (2021). Retrieved from <https://www.finteplahcp.com/hcp/fintepla-fenfluramine-oral-solution-ciii/>
[2] DrugPatentWatch. (2021). Fintepla (fenfluramine) Drug Profile. Retrieved from <https://www.drugpatentwatch.com/drugs/fintepla>